Discover 1,271 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,271
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
for
Single Gene NIPT
Location: Glendale AZ, Los Angeles CA, San Carlos CA,
Sponsor: Natera, Inc.
Sex: All
Age: 18+
Code: NCT06808880
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: Glendale AZ, Avondale AZ, Phoenix AZ, Scottsdale AZ,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 16+
Code: NCT06617325
Phase3, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Goodyear AZ, Chandler AZ, Gilbert AZ, San Diego CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase3, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Goodyear AZ, Phoenix AZ, Gilbert AZ, San Diego CA,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase3, Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
for
Refractory Rheumatoid Arthritis (RA),
Location: Phoenix AZ, Tucson AZ, Chula Vista CA, Tustin CA,
Sponsor: Artiva Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06991114
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
for
Psoriatic Arthritis, Overweight or Obesity
Location: Avondale AZ, Phoenix AZ, Chandler AZ, Tucson AZ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06864026
Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
for
SLE, SLE (Systemic Lupus)
Location: Avondale AZ, Tucson AZ, Salt Lake City UT, Plano TX,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18 - 70
Code: NCT06613360
Phase1, Recruiting
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
for
Arthritis, Psoriatic
Location: Avondale AZ, Phoenix AZ, Scottsdale AZ, Mesa AZ,
Sponsor: MoonLake Immunotherapeutics AG
Sex: All
Age: 18+
Code: NCT06641089
Phase3, Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
for
Fibromyalgia
Location: Glendale AZ, Phoenix AZ, Tucson AZ, Las Vegas NV,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07398417
Phase3, Recruiting
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
for
Eosinophilic Asthma
Location: Sun City AZ, Tucson AZ, Henderson NV, Newport Beach CA,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 70+
Code: NCT06750289
Phase3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Glendale AZ, Tempe AZ, Gilbert AZ, Tucson AZ,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
for
AL Amyloidosis
Location: Goodyear AZ, Tucson AZ, Irvine CA, Orange CA, Duarte CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06022939
Phase3, Recruiting
Quality of Life Assessment of Cryotherapy in Esophageal or Gastroesophageal Cancer
for
Esophageal Cancer
Location: Goodyear AZ
Sponsor: Western Regional Medical Center
Sex: All
Age: 18 - 70+
Code: NCT03285035
Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-Resistant Prostate Cancer
Location: Goodyear AZ, Scottsdale AZ, Tucson AZ, Albuquerque NM,
Sponsor: Kyntra Bio
Sex: Male
Age: 18+
Code: NCT06842498
Phase2, Recruiting
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
for
Advanced Colon Adenocarcinoma,
Location: Goodyear AZ, Corona CA, Upland CA, Irvine CA, Duarte CA,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07595874
Phase2, Recruiting
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
for
Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8,
Location: Goodyear AZ, Corona CA, Upland CA, Irvine CA,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07288034
Phase2, Recruiting
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
for
Resectable Colorectal Carcinoma,
Location: Goodyear AZ, Corona CA, Upland CA, Irvine CA,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07125729
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Goodyear AZ, Kingman AZ, Henderson NV, Las Vegas NV,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase2, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab